Patents by Inventor Rita G. Sattler

Rita G. Sattler has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods for monitoring C9ORF72 expression
    Patent number: 10577604
    Abstract: Disclosed herein are methods for monitoring expression of C9ORF72 mRNA and protein in an animal with C9ORF72 specific inhibitors. Such C9ORF72 specific inhibitors include antisense compounds.
    Type: Grant
    Filed: October 15, 2013
    Date of Patent: March 3, 2020
    Assignees: Ionis Pharmaceuticals, Inc., The Johns Hopkins University
    Inventors: C. Frank Bennett, Susan M. Freier, Jeffrey D. Rothstein, Christopher Donnelly, Rita G. Sattler
  • METHODS FOR MONITORING C9ORF72 EXPRESSION
    Publication number: 20160024496
    Abstract: Disclosed herein are methods for monitoring expression of C9ORF72 mRNA and protein in an animal with C9ORF72 specific inhibitors. Such C9ORF72 specific inhibitors include antisense compounds.
    Type: Application
    Filed: October 15, 2013
    Publication date: January 28, 2016
    Applicants: The Johns Hopkins University, Isis Pharmaceuticals, Inc.
    Inventors: C. Frank Bennett, Susan M. Freier, Jeffrey D. Rothstein, Christopher Donnelly, Rita G. Sattler
  • NEURODEGENERATIVE DISEASE DIAGNOSTIC COMPOSITIONS AND METHODS OF USE
    Publication number: 20120094295
    Abstract: The invention generally provides diagnostics that employ biomarkers altered in neurodegenerative disease, as well as methods for the use of such markers in monitoring disease progression and identifying agents useful for the treatment of a neurodegenerative disease.
    Type: Application
    Filed: November 20, 2009
    Publication date: April 19, 2012
    Applicant: The Johns Hopkins University
    Inventors: Rita G. Sattler, Jeffrey D. Rothstein, Richard Chipkin